drugset / Trial / NCT07295938
TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease
Phase 2
Recruiting
352 enrolled
Shanghai University of Traditional Chinese Medicine
Anhui Chest Hospital · collabBeijing Chest Hospital · collabChina-Japan Friendship Hospital · collabGuangzhou Chest Hospital. · collabHuashan Hospital · collabJiangxi Chest Hospital · collabShanghai Pulmonary Hospital, Shanghai, China · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Chinese herbs can facilitate sputum culture conversion, promote lesion absorption, and enhance clinical symptoms and quality of life for patients with Mycobacterium abscessus pulmonary disease (MAB-PD). The investigators aimed to evaluate the efficacy of Chinese herbs as adjunct therapy to improve cure rates or reduce recurrence rates during the continuation phase of MAB-PD treatment.
Timeline
- Start
- 2025-09-08
- Primary completion
- 2028-11
- Completion
- 2028-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chinese herbs-I | Traditional medicine (herbal / TCM) | — | — |
| Subject | Chinese herbs-II | Traditional medicine (herbal / TCM) | — | — |